🇺🇸 FDA
Patent

US 8492373

Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

granted A61KA61K31/395A61K31/519

Quick answer

US patent 8492373 (Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Jul 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K31/395, A61K31/519, A61P, A61P13/12